Advertisement

Topics

Diabetes drug may hold promise for Parkinson’s patients, notes new research

07:39 EDT 4 Aug 2017 | EPM Magazine

A new study, led by University College London, has demonstrated that a diabetes drug (exenatide) may offer potentially disease-modifying attributes to patients suffering from Parkinson’s disease.

Original Article: Diabetes drug may hold promise for Parkinson’s patients, notes new research

NEXT ARTICLE

More From BioPortfolio on "Diabetes drug may hold promise for Parkinson’s patients, notes new research"

Quick Search
Advertisement
 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...